Loading causes.
30,233
Votes
$66,547
Raised
$15,358
Display pool
Regulators move to curb a major home-care deal
UnitedHealth (through Optum) wants to buy Amedisys, a major home health and hospice provider. Regulators say the deal could cut competition in many local markets, which can mean fewer choices and higher costs for seniors and families. Winning means stopping the merger or, if it moves forward, enforcing strong remedies that protect real competition.
Home health and hospice care often happen when people are sick, older, or near the end of life. Families need options they can trust, close to home.
When one large company controls more of the insurance side and the care side, competition can shrink in many communities. Less competition can lead to higher costs, fewer provider choices, and pressure on care quality and workers.
UnitedHealth has major legal and lobbying resources and argues the deal is a harmless “vertical” merger with efficiencies. If regulators or courts accept weaker settlements, competition in local markets may not be protected.
Choose which strategies should receive funding this cycle.
Sign in to vote on this cause.
Discussion posting
No threads yet. New durable discussions will appear here once posted.
Impact updates will appear here after the first cycle closes.
